Brian Abrahams

Stock Analyst

(n/a)
# 4,648
Out of 4,655 analysts
416
Total ratings
n/a
Success rate
n/a
Average return

Stocks Rated by Brian Abrahams

Regeneron Pharmaceuticals
Nov 1, 2024
Maintains: Outperform
Price Target: $1,260$1,215
Current: $843.60
Upside: +44.03%
Galapagos NV
Nov 1, 2024
Maintains: Sector Perform
Price Target: $32$30
Current: $26.89
Upside: +11.57%
Incyte
Oct 30, 2024
Maintains: Sector Perform
Price Target: $67$72
Current: $76.13
Upside: -5.42%
Gilead Sciences
Oct 29, 2024
Reiterates: Sector Perform
Price Target: $75
Current: $89.51
Upside: -16.21%
Marinus Pharmaceuticals
Oct 25, 2024
Maintains: Sector Perform
Price Target: $3$1
Current: $0.33
Upside: +204.97%
Sarepta Therapeutics
Oct 21, 2024
Reiterates: Outperform
Price Target: $182
Current: $123.29
Upside: +47.62%
IGM Biosciences
Oct 18, 2024
Maintains: Outperform
Price Target: $17$20
Current: $16.22
Upside: +23.30%
Vertex Pharmaceuticals
Oct 9, 2024
Maintains: Sector Perform
Price Target: $425$437
Current: $471.12
Upside: -7.24%
Neurocrine Biosciences
Oct 8, 2024
Reiterates: Sector Perform
Price Target: $133
Current: $122.21
Upside: +8.83%
Sage Therapeutics
Oct 4, 2024
Downgrades: Underperform
Price Target: $10$4
Current: $6.05
Upside: -33.88%
Maintains: Sector Perform
Price Target: $32$34
Current: $40.47
Upside: -15.99%
Maintains: Outperform
Price Target: $106$108
Current: $86.54
Upside: +24.80%
Maintains: Outperform
Price Target: $292$269
Current: $173.79
Upside: +54.78%
Reiterates: Outperform
Price Target: $82
Current: $16.92
Upside: +384.63%
Reiterates: Outperform
Price Target: $29
Current: $11.17
Upside: +159.62%
Reiterates: Outperform
Price Target: $55
Current: $41.69
Upside: +31.93%
Maintains: Outperform
Price Target: $30$32
Current: $16.65
Upside: +92.19%
Maintains: Sector Perform
Price Target: $28$24
Current: $16.65
Upside: +44.14%
Reiterates: Outperform
Price Target: $3
Current: $0.90
Upside: +232.15%
Maintains: Sector Perform
Price Target: $13$12
Current: $9.14
Upside: +31.29%
Reiterates: Outperform
Price Target: $10
Current: $8.43
Upside: +18.62%
Reiterates: Outperform
Price Target: $12
Current: $9.09
Upside: +32.01%
Reiterates: Outperform
Price Target: $22
Current: $6.14
Upside: +258.31%
Reiterates: Outperform
Price Target: $50
Current: $3.84
Upside: +1,202.08%
Maintains: Outperform
Price Target: $54$45
Current: $14.52
Upside: +209.92%
Maintains: Sector Perform
Price Target: $25$15
Current: $10.95
Upside: +36.99%
Maintains: Sector Perform
Price Target: $12$9
Current: $1.08
Upside: +733.33%
Maintains: Sector Perform
Price Target: $21$33
Current: $50.30
Upside: -34.39%
Upgrades: Buy
Price Target: n/a
Current: $50.99
Upside: -